Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d’Ivoire: A randomized controlled superiority study

BACKGROUND: Moxidectin is a macrocyclic lactone registered for the treatment of human onchocerciasis. The drug has a good safety profile, large volume of distribution and a long elimination half-life. This paper reports tolerability data from the first use of moxidectin in persons with Wuchereria ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjerum, Catherine M., Koudou, Benjamin G., Ouattara, Allassane F., Lew, Daphne, Goss, Charles W., Gabo, Pascal T., King, Christopher L., Fischer, Peter U., Weil, Gary J., Budge, Philip J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538700/
https://www.ncbi.nlm.nih.gov/pubmed/37721964
http://dx.doi.org/10.1371/journal.pntd.0011633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538700/
https://www.ncbi.nlm.nih.gov/pubmed/37721964
http://dx.doi.org/10.1371/journal.pntd.0011633

Ejemplares similares